Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    Taking a daily vitamin to prevent type 1 diabetes?

    Wasserfall C, Atkinson MA.

    Diabetes. 2009 Jan;58(1):24-5. No abstract available. PMID: 19114727 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.

    Van YH, Lee WH, Ortiz S, Lee MH, Qin HJ, Liu CP.

    Diabetes. 2009 Jan;58(1):146-55. Epub 2008 Nov 4.PMID: 18984738 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Immunotherapy of type 1 diabetes.

    Li L, Yi Z, Tisch R, Wang B.

    Arch Immunol Ther Exp (Warsz). 2008 Jul-Aug;56(4):227-36. Epub 2008 Jul 29. Review.PMID: 18726144 [PubMed - indexed for MEDLINE]Related articles

    4.

    Insulin B-chain reactive CD4+ regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells.

    Bergerot I, Arreaza GA, Cameron MJ, Burdick MD, Strieter RM, Chensue SW, Chakrabarti S, Delovitch TL.

    Diabetes. 1999 Sep;48(9):1720-9.PMID: 10480600 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    CD8+CD28- regulatory T lymphocytes prevent experimental inflammatory bowel disease in mice.

    Ménager-Marcq I, Pomié C, Romagnoli P, van Meerwijk JP.

    Gastroenterology. 2006 Dec;131(6):1775-85. Epub 2006 Sep 8.PMID: 17087950 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Cytokine production by CD4+ and CD8+ T cells in mice following primary exposure to chemical allergens: evidence for functional differentiation of T lymphocytes in vivo.

    Moussavi A, Dearman RJ, Kimber I, Kemeny DM.

    Int Arch Allergy Immunol. 1998 Jun;116(2):116-23.PMID: 9652304 [PubMed - indexed for MEDLINE]Related articles

    7.

    Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.

    Suarez-Pinzon W, Rajotte RV, Mosmann TR, Rabinovitch A.

    Diabetes. 1996 Oct;45(10):1350-7.PMID: 8826970 [PubMed - indexed for MEDLINE]Related articles

    8.

    Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells.

    Battaglia M, Stabilini A, Draghici E, Migliavacca B, Gregori S, Bonifacio E, Roncarolo MG.

    Diabetes. 2006 Jun;55(6):1571-80.PMID: 16731819 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations.

    Zipris D, Hillebrands JL, Welsh RM, Rozing J, Xie JX, Mordes JP, Greiner DL, Rossini AA.

    J Immunol. 2003 Apr 1;170(7):3592-602.PMID: 12646622 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity.

    Yamanouchi J, Rainbow D, Serra P, Howlett S, Hunter K, Garner VE, Gonzalez-Munoz A, Clark J, Veijola R, Cubbon R, Chen SL, Rosa R, Cumiskey AM, Serreze DV, Gregory S, Rogers J, Lyons PA, Healy B, Smink LJ, Todd JA, Peterson LB, Wicker LS, Santamaria P.

    Nat Genet. 2007 Mar;39(3):329-37. Epub 2007 Feb 4.PMID: 17277778 [PubMed - indexed for MEDLINE]Related articles

    11.

    Mitogen-induced activation of mouse T cells increases kappa opioid receptor expression.

    Bidlack JM, Abraham MK.

    Adv Exp Med Biol. 2001;493:103-10. No abstract available. PMID: 11727755 [PubMed - indexed for MEDLINE]Related articles

    12.

    Type 1 diabetes: focus on prevention.

    von Boehmer H.

    Nat Med. 2004 Aug;10(8):783-4. No abstract available. PMID: 15286776 [PubMed - indexed for MEDLINE]Related articles

    13.

    Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.

    Chikamatsu K, Sakakura K, Whiteside TL, Furuya N.

    Head Neck. 2007 Feb;29(2):120-7.PMID: 17103408 [PubMed - indexed for MEDLINE]Related articles

    14.

    The diabetes type 1 locus Idd6 modulates activity of CD4+CD25+ regulatory T-cells.

    Rogner UC, Lepault F, Gagnerault MC, Vallois D, Morin J, Avner P, Boitard C.

    Diabetes. 2006 Jan;55(1):186-92.PMID: 16380492 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    T cells undergo rapid ON/OFF but not ON/OFF/ON cycling of cytokine production in response to antigen.

    Corbin GA, Harty JT.

    J Immunol. 2005 Jan 15;174(2):718-26.PMID: 15634891 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.

    Schuerwegh AJ, van Offel JF, Bridts CH, Stevens WJ, De Clerck LS.

    J Rheumatol. 2001 Aug;28(8):1793-9.PMID: 11508581 [PubMed - indexed for MEDLINE]Related articles

    17.

    Both CD4(+)and CD8(+)T cells are required for IFN-gamma gene expression in pancreatic islets and autoimmune diabetes development in biobreeding rats.

    El-Sheikh A, Suarez-Pinzon WL, Power RF, Rabinovitch A.

    J Autoimmun. 1999 Mar;12(2):109-19.PMID: 10047431 [PubMed - indexed for MEDLINE]Related articles

    18.

    Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse.

    Kadri N, Potiron N, Ouary M, Jegou D, Gouin E, Bach JM, Lieubeau B.

    Immunol Lett. 2007 Feb 15;108(2):129-36. Epub 2006 Dec 18.PMID: 17196260 [PubMed - indexed for MEDLINE]Related articles

    19.

    Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription.

    Muir A, Peck A, Clare-Salzler M, Song YH, Cornelius J, Luchetta R, Krischer J, Maclaren N.

    J Clin Invest. 1995 Feb;95(2):628-34.PMID: 7860747 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.

    Augstein P, Dunger A, Heinke P, Wachlin G, Berg S, Hehmke B, Salzsieder E.

    Biochem Biophys Res Commun. 2003 May 2;304(2):378-84.PMID: 12711326 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data